Dublin, Aug. 28, 2017 -- The "Worldwide Aortic Aneurysm Market Trends and Drivers, Restraints, and Opportunities 2017-2023" report has been added to Research and Markets' offering.
The Global Aortic Aneurysm Market is estimated to witness a CAGR of 6.6% during the forecast period 2017-2023. The aortic aneurysm market is analyzed based on three segments - type, product types, and regions.
The increasing lifestyle diseases and smoking population are the factors that increase the chances for aortic aneurysm. Along with this, the growing aging population, favorable reimbursement, and technological advancements in products are driving the growth of the aortic aneurysm market. However, lack of awareness about the disease, stringent regulatory approval procedures, and risk associated with the procedure are hampering the growth of the market. The main unmet need in the market is endoleaking, which increases the mortality rate.
Currently, the market players are developing technologically advanced stent grafts for the treatment of complex aortic aneurysm repairs. The EVAR segment contributed more than 70% of the total market share in 2016. A major focus in this segment is expected to drive the growth of the aortic aneurysm market in the future.
The market of aortic aneurysm is dominated by Cook Medical, Medtronic PLC, and W.L. Gore and Associates, who occupy around 85% of the market share. Other small players are adopting various strategies to increase their market share. Endologix acquired Trivascular to expand its product portfolio, thereby being able to address the current and future needs in the aortic aneurysm market.
In countries such as Australia, Germany, the US, and Switzerland, who have fee-for-service reimbursement system, the proportion undergoing AAA repair is higher compared with countries, such as Iceland, Sweden, Denmark, New Zealand, Hungary and Norway, who have a population-based reimbursement model.
Key Topics Covered:
1 Industry Outlook
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.3.1 Interventional Cardiology
3.3.2 Stents
3.3.3 Angioplasty
4 Market Outlook
4.1 Market Definition
4.2 Importance of Aortic Aneurysm Repair Devices
4.3 Complications of Aortic Aneurysm
4.4 Risk Factors for Aortic Aneurysm
4.5 Types of Aneurysm
4.6 Market Segmentation
4.7 Porter 5(Five) Forces
5 Market Characteristics
5.1 Evolution
5.2 Symptoms of Aortic Aneurysm
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising geriatric population
5.3.1.2 High prevalence of tobacco smoking
5.3.1.3 Growing acceptance for minimally invasive endovascular surgeries
5.3.1.4 Favorable reimbursement conditions
5.3.2 Opportunities
5.3.2.1 Market expansion opportunities in emerging nations
5.3.2.2 Mergers & acquisitions
5.3.2.3 Increasing clinical trials
5.3.3 Restraints
5.3.3.1 Stringent regulations for approval
5.3.3.2 Risk associated with the procedure
5.3.3.3 Lack of awareness
5.4 DRO - Impact Analysis
5.5 Key Stakeholders
6 Types: Market Size and Analysis
6.1 Overview
6.2 Abdominal Aortic Aneurysm
6.2.1 Procedure Type
6.2.1.1 Open surgery
6.2.1.2 Abdominal endovascular aneurysm repair
6.2.2 Location Types
6.3 Thoracic Aortic Aneurysm
6.3.1 Procedure Type
6.3.1.1 Open surgery
6.3.1.2 Thoracic endovascular aortic aneurysm
6.3.2 Location Types
7 Products: Market Size and Analysis
7.1 Overview
7.2 Stent Grafts
7.3 Catheters
7.4 Others
8 Regions: Market Size and Analysis
9 Competitive Landscape
9.1 Overview
10 Vendors Profile
10.1 MicroPort Scientific Corporation
10.2 Medtronic Plc
10.3 Terumo Corp.
10.4 Endologix Inc.
11 Companies to Watch For
11.1 Cook Medical Inc.
11.2 W.L. Gore & Associates
11.3 Maquet GmbH (Getinge Group)
11.4 Jotec GmbH
11.5 Boston Scientific Corp.
11.6 Lombard Medical Technologies PLC
For more information about this report visit https://www.researchandmarkets.com/research/t9xp3n/worldwide_aortic
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Devices


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Washington Post Publisher Will Lewis Steps Down After Layoffs
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 



